SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Scotland approves tebentafusp for metastatic uveal melanoma, a rare eye cancer with a median survival of around 12 months.
Medscape News UK

Source link : https://www.medscape.com/viewarticle/smc-accepts-first-drug-improve-survival-uveal-melanoma-2026a1000npg?src=rss

Author :

Publish date : 2026-07-14 10:21:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Woman’s Hour – ADHD and hormones, When co-habiting couples separate, God of War

PPE failures left NHS staff poorly protected and wasted billions, Covid inquiry finds

Related Posts

Paid Parental Leave for Med School Faculty Often Lacking

Returned Travelers: Could More Than Souvenirs Come Home?

PPE failures left NHS staff poorly protected and wasted billions, Covid inquiry finds

Woman’s Hour – ADHD and hormones, When co-habiting couples separate, God of War

How deadly have the heatwaves in England and Wales been?

Anemia Leads List of Factors That Affect BLVR Failure

Paid Parental Leave for Med School Faculty Often Lacking

Returned Travelers: Could More Than Souvenirs Come Home?

PPE failures left NHS staff poorly protected and wasted billions, Covid inquiry finds

SMC Accepts First Drug to Improve Survival in Uveal Melanoma

Woman’s Hour – ADHD and hormones, When co-habiting couples separate, God of War

How deadly have the heatwaves in England and Wales been?

Anemia Leads List of Factors That Affect BLVR Failure

Finding the Mystery to Trigger-Induced Atrial Fibrillation

Categories

Archives